Price target
0.920.000.00%
The 1 analyst offering 1 year price forecasts for 4E2 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 1 analyst giving stock ratings to 4E2 in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
4E2 EPS for the last quarter is −0.25 EUR despite the estimation of −0.39 EUR. In the next quarter EPS is expected to reach −0.38 EUR. Track more of Relmada Therapeutics Inc financials and stay on top of what is up with the company.
In the next quarter Relmada Therapeutics Inc revenue is expected to reach 0.00 EUR. Check out Relmada Therapeutics Inc revenue and earnings and make informed decisions.
According to analysts, 4E2 price target is 0.92 EUR with a max estimate of 0.92 EUR and a min estimate of 0.92 EUR. Check if this forecast comes true in a year, meanwhile watch Relmada Therapeutics Inc stock price chart and keep track of the current situation with 4E2 news and stock market news.